| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 10/23/2008 | US20080262198 Tyrosine modified protein for use in as components of crosslinked fibers, emulsifiers and moleclular scaffolds |
| 10/23/2008 | US20080261998 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors |
| 10/23/2008 | US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection |
| 10/23/2008 | US20080260829 Bone morphogenic proteins (bmp); cell adhesion modulating agent; peptidomimetics of cyclic peptides comprising classical cadherin cell adhesion recognition (CAR) sequences; modulate cell adhesion and improve drug delivery |
| 10/22/2008 | EP1981901A1 Amino acid derivatives |
| 10/22/2008 | EP1560590B1 Synthetic complementary peptides and ophthalmologic uses thereof |
| 10/22/2008 | EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor |
| 10/22/2008 | EP1368371B1 Transfection complexes |
| 10/22/2008 | CN100427139C Water-soluble shps as novel alkylating agents |
| 10/21/2008 | US7439345 Supramolecular pairing system, its preparation and use |
| 10/21/2008 | US7439333 Vascular endothelial growth factor 2 |
| 10/21/2008 | US7439329 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase |
| 10/21/2008 | US7439319 Selective substrates for matrix metalloproteinases |
| 10/21/2008 | US7439226 Serine protease inhibitors |
| 10/21/2008 | US7438917 Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
| 10/21/2008 | CA2171334C Substituted thiazolo[3,2-a]azepine derivatives |
| 10/16/2008 | WO2008124148A2 Sulfur compounds as inhiibitors of hepatitis c virus ns3 serine protease |
| 10/16/2008 | WO2008123607A1 Method for production of dipeptide |
| 10/16/2008 | WO2008122794A2 Breast cancer methods, medicaments and agents |
| 10/16/2008 | WO2008051477A3 Hcv ns3 protease inhibitors |
| 10/16/2008 | WO2008014240A3 Dimeric iap inhibitors |
| 10/16/2008 | WO2008013953A3 Tyrosine phosphorylation sites |
| 10/16/2008 | WO2007112045A3 Use of somatostatin agonists to treat medullary thyroid carcinoma |
| 10/16/2008 | US20080255248 Coupling a stabilizing group-oligopeptide conjugate with the free therapeutic agent, binding with a polymeric resin forming a therapeutic agent-polymeric resin complex; high specificity of action, a reduced toxicity, an improved stability in the serum and blood |
| 10/16/2008 | US20080255073 Compounds for sustained release of orally delivered drugs |
| 10/16/2008 | US20080253964 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules |
| 10/16/2008 | CA2683639A1 Sulfur compounds as inhiibitors of hepatitis c virus ns3 serine protease |
| 10/15/2008 | EP1669463B1 Casein hydrolyzate, process for producing the same and use thereof |
| 10/15/2008 | CN101287988A Methods and compositions for diagnosis and treatment of influenza |
| 10/14/2008 | US7435718 CXCR4 antagonist treatment of hematopoietic cells |
| 10/14/2008 | US7435716 Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia |
| 10/14/2008 | CA2171625C Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 10/09/2008 | WO2008119208A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof |
| 10/09/2008 | WO2008057873A3 Inhibitors of hepatitis c virus |
| 10/09/2008 | WO2008008463A3 METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPβ |
| 10/09/2008 | US20080249026 PEPTIDES AND THEIR UTILITY IN MODULATION OF BEHAVIOR OF CELLS EXPRESSING alpha3beta1 INTEGRINS |
| 10/09/2008 | US20080249021 Biologically active peptides and their use for repairing injured nerves |
| 10/09/2008 | US20080249004 Method of Modulating Cell Survival, Differentiation and/or Synaptic Plasticity |
| 10/09/2008 | US20080247988 Methods of making and using surfactant polymers |
| 10/09/2008 | US20080247950 Proteases of human kallikrein 2 (hK2); tissue imaging |
| 10/08/2008 | EP1978025A1 Novel kappa receptor selective opioid peptides |
| 10/08/2008 | EP1833978B1 Tripeptide and tetrapeptide thioethers |
| 10/08/2008 | EP1833842B1 Tripeptide and tetrapeptide sulfones |
| 10/08/2008 | EP1781596B1 Amino acid derived prodrugs of propofol compositions and uses thereof |
| 10/08/2008 | EP1485346B1 Novel positively charged lipids and liposomes comprising the positively charged lipids |
| 10/08/2008 | EP1064298B1 Inhibitors of caspases |
| 10/08/2008 | CN101282978A Macrocylic inhibitors of hepatitis c virus |
| 10/08/2008 | CN101282657A Methods for the use of branched chain amino acids |
| 10/07/2008 | US7432349 Tumor suppressor proteinfor use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 10/07/2008 | US7432343 MAIL: Molecule possessing Ankyrin repeats Induced by Lipopolysaccharide or I theta B-zeta; antigenic peptide; detection and treatment of carcinomas, especially metastatic breast cancer |
| 10/07/2008 | US7432061 Assays for measuring matrix metalloproteinase activities |
| 10/02/2008 | WO2008117730A1 Composition for preventing or treating lung disease |
| 10/02/2008 | WO2008106130A3 Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| 10/02/2008 | WO2008083288A3 Purifiction of romidepsin |
| 10/02/2008 | WO2008050161A3 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds |
| 10/02/2008 | US20080242837 Peptide compositions |
| 10/02/2008 | US20080242836 Deblocking, deprotecting; HPLC |
| 10/02/2008 | US20080242835 For treatment of hepatitis C |
| 10/02/2008 | US20080242621 Reducing blood glucose; increase insulin sensitivity; antidiabetic agents |
| 10/02/2008 | US20080242620 Stimulation T-cell transformation; cell proliferation disorders; anticancer agents; antiscarcoma; mixture of tripeptide and carrier ; nutrient |
| 10/02/2008 | US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders |
| 10/02/2008 | US20080242600 Oral bioavailability; intestine permeability; metabolism disorders such as obesity |
| 10/02/2008 | US20080241905 Retroviral vector comprising nucleotide sequences coding collagen domain for use in wound healing; tissue repair and engineering; regenerative medicine |
| 10/02/2008 | US20080241128 Antibodies; anticancer agents; autoimmune disorders |
| 10/02/2008 | CA2681598A1 Hydrazido-peptides as inhibitors of hcv ns3-protease |
| 10/02/2008 | CA2681593A1 Preventive or therapeutic composition for liver disease |
| 10/01/2008 | EP1975153A2 Protease inhibitors |
| 10/01/2008 | EP1973946A2 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 10/01/2008 | EP1973930A2 Cyclic peptides and their use in treating advanced stage neuroblastoma |
| 10/01/2008 | EP1973929A2 Anticoagulation of human blood ex vivo |
| 10/01/2008 | EP1973928A2 Self-assembled fmoc-ff hydrogels |
| 10/01/2008 | EP1973548A2 Soft protease inhibitors and pro-soft forms thereof |
| 10/01/2008 | EP1496877B1 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 10/01/2008 | CN100422208C Hemiasterlin analogs |
| 10/01/2008 | CN100422207C Process for producing dipeptide L-amino acid amide hydrolase to be used therein and process for producing L-amino acid amide hydrolase |
| 09/30/2008 | USRE40525 Hepatitis C inhibitor tri-peptides |
| 09/30/2008 | US7429639 SSX-2 peptides presented by HLA class II molecules |
| 09/30/2008 | US7429381 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 09/25/2008 | WO2008115337A1 Sulfur-protected mercaptoacetylglycylglycylglycine |
| 09/25/2008 | WO2008060776A3 Atap peptides, nucleic acids encoding the same and associated methods of use |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234344 Amino Acid and Peptide Conjugates of Arylalkylic Acids for Cosmetic Use |
| 09/25/2008 | US20080234205 Antineoplastic peptides |
| 09/25/2008 | US20080233629 Fusion protein for use in genration of preferential biopolymers in plants |
| 09/25/2008 | US20080233136 Biologically Active Peptides |
| 09/24/2008 | EP1972636A1 Cycloalkylcarbonylamino acid derivative and process for producing the same |
| 09/24/2008 | EP1971580A1 Piperazine compounds with a herbicidal action |
| 09/24/2008 | CN101273052A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273042A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273030A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN100420746C Design and fermented production of recombinant peptide for reducing blood pressure |
| 09/23/2008 | US7427611 4-[(3-aminopropyl) (ethyl)amino]-2-{[1-(carboxymethyl)-2-oxo-2, 3, 4, 5-tetrahydro-1H-1benzazepin-3-yl]amino}carbonyl)-cyclopentyl]methyl}-4-oxobutanoic acid; neutral endopeptidase or human soluble endopeptidase (hSEP) inhibitors; cardiovascular diseases, apoptosis, stroke, neurodegenerative disorder |
| 09/23/2008 | US7427600 mesalamine covalently attached to carrier peptide at C-terminus, interspersed and/or side chain; releasing into bloodstream; reducing dosage |
| 09/23/2008 | US7427599 stimulating T-cell transformation; cell proliferative disorder, anti-cancer, and/or anti-sarcoma |
| 09/23/2008 | US7427591 Suppression of immune response via inhibition of cathepsin S |
| 09/18/2008 | WO2008095033A3 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 09/18/2008 | WO2008057235A9 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes |
| 09/18/2008 | WO2007121124A3 Hcv inhibitors comprising beta amino acids and their uses |
| 09/18/2008 | US20080227975 Method of producing fr901228 |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |